PRMD (Primemd) EV-to-EBIT: -0.13 (As of Jul. 12, 2026)


What is Primemd EV-to-EBIT?

Primemd PRMD -72.73% EV-to-EBIT is -0.13 as of Jul. 12, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Primemd's Enterprise Value is $0.01 Mil. Primemd's EBIT for the trailing twelve months (TTM) ended in Dec. 2008 was $-0.04 Mil. Therefore, Primemd's EV-to-EBIT for today is -0.13.

The historical rank and industry rank for Primemd's EV-to-EBIT or its related term are showing as below:

PRMD's EV-to-EBIT is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 15.815
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Primemd's Enterprise Value for the quarter that ended in Dec. 2008 was $0.15 Mil. Primemd's EBIT for the trailing twelve months (TTM) ended in Dec. 2008 was $-0.04 Mil. Primemd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2008 was -25.25%.

Primemd  (OTCPK:PRMD) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Primemd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2008 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2008 ) =EBIT / Enterprise Value (Q: Dec. 2008 )
=-0.039/0.154475
=-25.25 %

Primemd's Enterprise Value for the quarter that ended in Dec. 2008 was $0.15 Mil.
Primemd's EBIT for the trailing twelve months (TTM) ended in Dec. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Primemd EV-to-EBIT Related Terms

Primemd EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Primemd's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Primemd EV-to-EBIT Chart

Primemd Annual Data
Trend Mar98 Mar99 Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.89 2.30 1.72 1.80 -0.16

Primemd Quarterly Data
Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Primemd EV-to-EBIT Competitor Comparison

For the Medical Care Facilities subindustry, Primemd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Primemd EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Primemd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Primemd's EV-to-EBIT falls into.


Primemd EV-to-EBIT Calculation

Primemd's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.005/-0.039
=-0.13

Primemd's current Enterprise Value is $0.01 Mil.
Primemd's EBIT for the trailing twelve months (TTM) ended in Dec. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -0.13 mean?
Primemd (PRMD) has a EV-to-EBIT of -0.13 as of Jul. 12, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Primemd and its competitors.
Is Primemd's EV-to-EBIT too high?
Primemd's current EV-to-EBIT is -0.13.
How does Primemd's EV-to-EBIT compare to competitors?
Primemd's EV-to-EBIT of -0.13 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBIT is 15.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.82, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Primemd and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Primemd's current EV-to-EBIT is -0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Primemd stock overvalued right now?
Primemd (PRMD) has a current EV-to-EBIT of -0.13. The current EV-to-EBIT is -0.13. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Primemd (PRMD), the current EV-to-EBIT is -0.13 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Primemd Business Description

Address 9039 Antares Avenue, Suite No. E2, Columbus, OH, USA, 43240
Primemd Inc is a multispecialty professional services company. The company employs physicians, nurse practitioners, medical assistants to deliver services. Its services include Pediatrics; Primary Care; Spine and Pain Management; Urgent Care and others.